Paper41205263
Resolution Pharmacology: State-of-the-art and therapeutic landscape.
Perretti M and 1 other. Pharmacol Rev, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Resolution Pharmacology: State-of-the-art and therapeutic landscape. Papers, record 41205263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41205263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Inflammation | Major topic |
| Anti-Inflammatory Agents | Major topic |
| Inflammation Mediators | Major topic |
| Humans | |
| Animals |
Source PubMed
References291
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38718314 | An LGR6 frameshift variant abrogates receptor expression on select leukocyte subsets and is associated with viral infections. | Blood | 2024 | https://conductscience.org/library/papers/38718314 | PubMed |
| 2 | 15753205 | Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. | J Exp Med | 2005 | https://conductscience.org/library/papers/15753205 | PubMed |
| 3 | 34603288 | Formyl Peptide Receptors and Annexin A1: Complementary Mechanisms to Infliximab in Murine Experimental Colitis and Crohn's Disease. | Front Immunol | 2021 | https://conductscience.org/library/papers/34603288 | PubMed |
| 4 | 16091493 | A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. | J Clin Endocrinol Metab | 2005 | https://conductscience.org/library/papers/16091493 | PubMed |
| 5 | 38347157 | Sanofi buys Inhibrx and drug for alpha-1 antitrypsin deficiency for US$1.7 billion. | Nat Rev Drug Discov | 2024 | https://conductscience.org/library/papers/38347157 | PubMed |
| 6 | 22957142 | Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA. | Sci Rep | 2012 | https://conductscience.org/library/papers/22957142 | PubMed |
| 7 | 28694081 | Deletion of 12/15-lipoxygenase accelerates the development of aging-associated and instability-induced osteoarthritis. | Osteoarthritis Cartilage | 2017 | https://conductscience.org/library/papers/28694081 | PubMed |
| 8 | 27730665 | Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949. | Br J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/27730665 | PubMed |
| 9 | 40181186 | Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis. | EMBO Mol Med | 2025 | https://conductscience.org/library/papers/40181186 | PubMed |
| 10 | 17267386 | Resolution of inflammation: state of the art, definitions and terms. | FASEB J | 2007 | https://conductscience.org/library/papers/17267386 | PubMed |
| 11 | 22927428 | Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22927428 | PubMed |
| 12 | 9134220 | Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. | Br J Pharmacol | 1997 | https://conductscience.org/library/papers/9134220 | PubMed |
| 13 | 18802107 | Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. | J Immunol | 2008 | https://conductscience.org/library/papers/18802107 | PubMed |
| 14 | 32601335 | Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. | Nat Med | 2020 | https://conductscience.org/library/papers/32601335 | PubMed |
| 15 | 20363975 | Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner. | J Immunol | 2010 | https://conductscience.org/library/papers/20363975 | PubMed |
| 16 | 39160534 | CB2 expression in mouse brain: from mapping to regulation in microglia under inflammatory conditions. | J Neuroinflammation | 2024 | https://conductscience.org/library/papers/39160534 | PubMed |
| 17 | 22743999 | Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation. | Cell Death Differ | 2012 | https://conductscience.org/library/papers/22743999 | PubMed |
| 18 | 31442676 | The angiotensin converting enzyme 2/angiotensin-(1-7)/Mas Receptor axis as a key player in alveolar bone remodeling. | Bone | 2019 | https://conductscience.org/library/papers/31442676 | PubMed |
| 19 | 23043160 | Proresolution therapy for the treatment of delayed healing of diabetic wounds. | Diabetes | 2013 | https://conductscience.org/library/papers/23043160 | PubMed |
| 20 | 12471142 | An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile. | J Immunol | 2002 | https://conductscience.org/library/papers/12471142 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42713106 | Macrophage plasticity and metabolic control in muscle repair and disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42713106 | PubMed |
| 42473331 | Engineered probiotics platform for resolvin E1 biosynthesis confers protection against inflammatory disease. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42473331 | PubMed |
| 41516407 | Inflammation and Resolution in Obesity-Related Cardiovascular Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41516407 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41205263
GET https://conductscience.org/api/papers/v1/41205263/references?page=2